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The pathogenesis of Kaposi’s sarcoma (KS), a tumor of
probable vascular origin, remains an enigma. It is still
unclear whether KS is a true malignancy or whether it
represents a reactive polyclonal process. Using both an
immunohistochemical and an immunoblot approach, we
found that cells derived from KS lesions express significant
levels of Bcl-2, a protein known to prolong cellular
viability and to antagonize apoptosis. Bcl-2 expression
was found in AIDS-related KS-derived cells, as well as
in cells derived from iatrogenic and sporadic KS, indicat-
ing that Bcl-2 upregulation may be important in the
pathogenesis of KS regardless of its epidemiologic form.
By contrast, fibroblasts and dermal microvascular endo-
thelial, cells which are the probable vascular progenitors
of KS cells, expressed low levels of Bcl-2. The expression
Kaposi’s sarcoma (KS) is an angioproliferative disease thathas aroused considerable interest of late, as it is one ofthe major clinical manifestations found in patients withthe acquired immune deficiency syndrome (AIDS).Until the AIDS epidemic, this tumor was identified in
three different settings: classic KS, African-endemic KS, and immuno-
suppressive drug-related KS. All forms of KS have the same histology
characterized by a prominent angiogenesis and by the proliferation of
spindle-shaped cells that are considered to be the tumor cells of KS.
The histogenetic origin of the spindle cells remains controversial. A
widely held view is that these cells derive from endothelial cells (EC),
though they express macrophage antigens and fibroblast markers.
Whether KS is a true malignancy or a polyclonal proliferation is also
unknown. Separate lesions from the same patients are derived from an
identical clone, which would favor metastatic spread from a common
source (Rabkin et al, 1997). On the other hand, KS shows high
incidence of spontaneous remission, contains low levels of DNA
aneuploidy, and lacks nuclear atypia, which would favor a nonmalignant
process (Fukunaga and Silverberg, 1990; Simonart et al, 1997). Sup-
porting this view, cells derived from KS biopsies grow transiently in
culture and occasionally show malignant features such as karyotypic
abnormalities and the ability to produce malignant tumors in immuno-
deficient mice (Roth et al, 1988; Lunardi et al, 1995). Finally, a mixture
of cytokines and growth factors secreted by KS cells has been shown
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of Bcl-2 in KS-derived cells was associated with a long-
term survival in serum-deprived conditions, a situation
that has been shown to induce apoptosis in various cell
types. Incubation of fibroblasts or of dermal microvascu-
lar endothelial cells with KS cell-free supernatants did
not enhance Bcl-2 expression, suggesting that Bcl-2
expression is not mediated by an agent released by KS
cells. Analogously, KS supernatants failed to promote
the viability of fibroblasts and of dermal microvascular
endothelial cells cultured in serum-free conditions. Our
findings suggest that the spindle cells derived from KS
have a survival advantage and may adequately represent
the tumor cells of KS. Key words: apoptosis/dermal microvas-
cular endothelial cell/tumor. J Invest Dermatol 111:349–353,
1998
to alter the normal physiology of EC, leading to the emergence of
activated EC (Fiorelli et al, 1995).
The current hypothesis to explain the formation and development
of KS lesions is a multistep pathway involving cytokine dysregulation,
active infection by HIV-1 and/or by a new herpesvirus designated
human herpesvirus 8 (HHV-8), or KS-associated herpesvirus, over-
expression of integrins, and escape from programmed cell death
(apoptosis) (Chang et al, 1994; Bohan Morris et al, 1996; Noel et al,
1996; Pammer et al, 1996). The pathogenic links between these steps
remain unclear. One of the most important negative regulators of
apoptosis is Bcl-2 and its related proteins, which confer a survival
advantage to a variety of cell types including lymphoid cells, fibroblasts,
melanocytes, epithelial, and neuroneal cells (Tsujimoto et al, 1985;
Reed, 1994; Lu et al, 1995; Kroemer, 1997). The extended cell survival
due to Bcl-2 may lead to subsequent acquisition of genetic changes
resulting ultimately in tumor progression. Recent studies have shown
strong Bcl-2 expression among the spindle-shaped tumor cells of
cutaneous KS lesions (Bohan Morris et al, 1996; Dada et al, 1996).
Another study has revealed weak Bcl-2 immunoreactivity but over-
expression of Bcl-xl, another protein that prevents apoptosis (Foreman
et al, 1996).
In this study, we have investigated the expression of Bcl-2 by
cultured KS cells derived from different epidemiologic forms of KS.
Fibroblasts and dermal microvascular EC, which are the probable
vascular progenitors of KS cells, served as controls. Furthermore, we
have tested whether supernatants from KS cell cultures can induce the
expression of Bcl-2 in fibroblasts or EC or enhance their survival after
serum withdrawal, a stimulus that has been shown to induce apoptosis
in various cell types (Hase et al, 1994).
MATERIALS AND METHODS
Cell cultures Five independent KS cell cultures were derived from cutaneous
KS biopsies from three AIDS patients (KS-1, patch-stage KS; KS-2 and 23,
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nodular-stage KS), from one renal recipient transplant (KS-4, plaque-stage KS),
and from one patient with sporadic KS (KS-5, plaque-stage KS). Cultures were
established similarly as previously described (Benelli et al, 1994). Briefly,
fresh lesions were minced inyo small pieces and enzymatically digested with
collagenase (1 mg per ml) from Clostridium histolyticum for 90 min. Cells were
grown without additional growth factors in minimum essential medium D-Val
(Gibco, Paisly, Scotland) containing 10% inactivated fetal calf serum (Gibco),
1% nonessential amino acids, penicillin (100 U per ml), and streptomycin
(100 µg per ml). Cells isolated from these cultures were characterized as KS
cells morphologically (spindle-shaped morphology) and immunohistochemically
(positivity for laminin, vimentin, and collagen IV in the majority of the cells;
positivity for α-smooth muscle actin and ICAM-1 in up to 50% of the cells,
and negativity for cytokeratin, ICAM-2, ELAM-1, VCAM-1, CD4, CD34,
CD40, CD45), in accordance with previous published reports (Roth et al,
1988; Benelli et al, 1994; Pammer et al, 1996; Simonart et al, 1996). The
experiments presented here were performed on cell cultures at the third to the
fourteenth passage for immunohistochemistry, at the seventh to the thirteenth
passage for western blot analysis, and at the seventh to the eighth passage
(doubling time, 4–5 d) for cell survival kinetics.
Dermal microvascular EC were cultured by a method similar to the one
reported by Kluger et al (1997). EC were isolated from normal adult breast skin
obtained as discarded tissue from reduction mammoplasties (Department of
Plastic Surgery, Erasme University Hospital). Informed consent was obtained
from the patients. Fresh skin was stretched flat and sectioned horizontally. After
a 60 min incubation in 2 mg dispase II per ml (Boehringer, Mannheim,
Germany) at room temperature, the epidermis was peeled off and cells from
both sides of the underlying epidermis were gently scraped into RPMI (Gibco)
and filtered through a 70 µM nylon mesh. The filtrate, containing single cells,
was washed once in minimum essential medium D-Val and plated onto tissue
culture plastic precoated with 5 µg fibronectin per cm2 (Sigma). EC were
allowed to attach µ4 h before gentle aspiration (to remove cell debris) and
addition of fresh media. This medium consists of minimum essential medium
D-Val (Gibco) supplemented with 20% fetal calf serum (Gibco), glutamine
2 mM, penicillin (100 U per ml) and streptomycin (100 µg per ml), 100 µg
heparin per ml (Braun), 50 µg endothelial cell growth factor per ml (Fluka),
0.5 mM dibutyryl-cAMP, and 3.3 µM isobutyl-methyl-xanthine (both from
Sigma). FACS analysis revealed that .90% of the cells were positive for von
Willebrand factor. EC were used at passage 3–4 (doubling time, 2–3 d).
Human dermal fibroblasts obtained from foreskins were cultured in RPMI
(Gibco) containing 10% fetal calf serum (Gibco), 1% nonessential amino acids,
penicillin (100 U per ml), and streptomycin (100 µg per ml). These were used
at passage 7–8 (doubling time, 3–4 d).
Immunohistochemistry Immunohistochemistry using I-19 (Bax) and N-
19 (Bcl-2) rabbit polyclonal antibodies (Santa Cruz Biotechnology) and Ab-1
(Bcl-2) (Oncogene Research Products, Calbiochem) monoclonal antibody was
carried out on cytospins. Briefly, subconfluent cell cultures were harvested and
made into single-cell suspension by trypsinization. For I-19 (Bax) and N-19
(Bcl-2), the cytospins preparations were incubated in 3% (vol/vol) H2O2 in
methanol for 1 h at room temperature. After permeabilization with 0.1%
saponin, the samples were incubated in normal goat serum for 30 min to block
nonspecific interactions, and then anti-Bax or anti-Bcl-2 antibodies were applied
at the dilution of 1 µg per ml overnight at 4°C. Normal rabbit immunoglobin
fraction (Dako, Glostrup, Denmark) at the same concentration as the primary
antibodies served as negative controls. Immunohistochemical staining was
achieved with the PK-4001 Vectastain ABC Kit (Vector Laboratories,
Burlingame, CA). The slides were counterstained with hematoxylin. For Ab-
1 (Bcl-2) monoclonal antibody, the samples were fixed in formol for 1 h at
room temperature and then microwaved for 2 3 5 min in a citrate buffer,
pH 6. After blocking with normal goat serum 1/20 for 30 min, the cytospins
were incubated with 5 µg Bcl-2 (Ab-1) monoclonal antibody per ml and then
with Euvision1/HRP (Dako). Peroxidase activity was developed with 3,39-
diaminobenzidine tetrahydrochloride (0.012% in phosphate-buffered saline) and
H2O2 (0.1%) and the cells were counterstained with hematoxylin.
Western blot analysis of protein expression Confluent cell cultures were
washed with complete phosphate-buffered saline and lyzed in sodium dodecyl
sulfate buffer (5% β-mercaptoethanol, 10% glycerol, 80 mM sodium dodecyl
sulfate, 60 mM Tris, pH 6.8). Lysates from MCF-7 cells were used as a
positive control. For each sample, a total quantity of 100 µg of protein was
electrophoresed on a 10%–17% sodium dodecyl sulfate-polyacrylamide linear
gradient slab gel, in Tris-buffered saline solution. After the electrophoresis, the
proteins were electrophoretically transferred to nitro-cellulose sheets. The blots
were subsequently incubated for 1 h in 1% fat-free milk in TBS and for 18 h
with Bcl-2 (Ab-1) monoclonal antibody at a 2 µg per ml concentration in TBS
(20 mM Tris, 125 mM NaCl). After extensive washing in TBS, the immune
complex was detected with a biotinylated anti-mouse Ig (diluted 1:250 in
TBS), serving as a binding bridge to biotin-streptavidin peroxydase preformed
complexes (Amersham, Little Chalfont, U.K.) used at the same dilution.
Preformed complex was detected by photographic recording of the chemilumin-
escence (ECL) emitted by a H2O2 reacting probe, using the Boehringer kit.
The immunoblots were scanned with a Microtek Phantom 4800 apparatus.
Induction of programmed cell death by serum deprivation
Subconfluent cell cultures were induced to undergo programmed cell death by
serum deprivation as described by He´bert et al (1994). In brief, the fetal calf
serum containing medium was removed. The cells were then washed two times
with serum-free medium in order to remove residual cell-associated fetal calf
serum. After the second rinse, the serum-free medium was placed onto the
monolayers cultures, which were incubated at 37°C for various periods of time
and assayed for viability as described below. For control experiments, the
medium was replaced with fresh medium containing 10% fetal calf serum.
Incubation of control cells with KS cells supernatants Conditioned
media from KS cells were obtained by washing confluent KS cell monolayers
twice with phosphate-buffered saline and incubating them for 48 h with serum-
free Mem D-Val. The supernatants were then collected, centrifugated to
eliminate cell debris and filtered through 0.45 µm pore size filters to eliminate
eventual residual cells. Fibroblasts and EC cultures were washed twice in serum-
free medium, and after the second rinse, further incubated with the KS cells
conditioned media.
Viability tests of serum-deprived cultures Viability after serum deprivation
was determined by harvesting the different cell cultures after various time
intervals. Cells in individual monolayer cultures were harvested and made into
single-cell suspension by trypsinization. The cell suspension was then incubated
for 3 min with trypan blue dye. The number of viable cells was estimated as
the percentage of cells remaining negative to the blue dye staining after trypan
blue exclusion.
RESULTS
High levels of Bcl-2 in KS-derived cells In a series of experiments
we have examined cultured KS cells for the expression of Bcl-2 and
Bax and compared them with EC and fibroblasts. We found that Bcl-
2 protein was readily immunocytochemically detectable in the majority
of KS cells (Fig 1), as was Bax, yet with a much lower staining
intensity. The antigen recognized by both Bcl-2 antibodies was
cytoplasmic, corresponding to the described localization of the Bcl-2
protein. Interestingly, positive staining for Bcl-2 was observed in AIDS-
related KS-derived cells, as well as in cells obtained from iatrogenic
and sporadic KS. The expression of Bcl-2 in KS cells was more
carefully studied in KS-1, -2, and -3, all cell cultures that were isolated
from the same epidemiologic setting (AIDS associated). Interestingly,
the percentage of positive cells was higher in the AIDS-KS cells derived
from more advanced lesions (KS-2 and -3, nodular-stage KS) (40%–
55%) than in those derived from a macular lesion (KS-1, patch-stage
KS) (25%–35%). Further studies are of course needed to establish a
possible correlation between the histologic stage of KS and the in vitro
expression of Bcl-2. Under similar conditions of culture, EC and
fibroblasts demonstrated weak Bcl-2 staining.
To further confirm the overexpression of Bcl-2 in KS-derived cells,
immunoblot analysis was performed. As depicted in Fig 2, the Ab-1
(Bcl-2) monoclonal antibody detected a protein of µ24 kDa corres-
ponding with the size expected for the Bcl-2 proto-oncogene in KS-
derived cells and in the malignant breast cell line MCF-7, but neither
in EC nor in fibroblasts.
Comparative survival kinetics of EC, KS cells, and fibroblasts
cultured in serum-free conditions show enhanced cell viability
of KS cells Previous studies indicated that cell death induced by
serum or growth factor deprivation occurs through apoptosis (Hase
et al, 1994). The viability of the cells was examined by staining with
trypan blue.
As shown in Fig 3, there were considerable differences in the time
course of cell death between EC, fibroblasts, and KS cells. Within
48 h of serum withdrawal, all the EC had detached from the plate,
whereas the survival remained unaltered in fibroblasts and KS cells.
After 15 d of serum deprivation, the majority of KS cells were alive,
whereas a substantial proportion of control fibroblastic cells took the
dye. KS cell viability was confirmed by the reinitiation of DNA
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Figure 1. Bcl-2 overexpression in KS-derived cells. Immunostaining of
KS-derived cells (a) and EC (b) with N-19 (Bcl-2) polyclonal antibody;
(c) negative control. Scale bars: 100 µm.
Figure 2. Immunoblot analysis of Bcl-2 in KS-derived cells and in
control cells. Cells lysates (100 µg of protein for each sample) were separated
on a 10%–17% sodium dodecyl sulfate polyacrylamide gel and electrophoretically
transferred to nitrocellulose sheets. The proteins were immunoblotted with
anti-Bcl-2 monoclonal antibody (Ab-1). The immunoblots were scanned with
a Microtek Phantom 4800 apparatus. Lane 1, KS-1 cells; lane 2, KS-2 cells; lane
3, KS-3 cells; lane 4, MCF7 cells; lane 5, EC; lane 6, fibroblasts.
synthesis (data not shown) and cell growth after resuspension in
medium supplemented with 10% fetal calf serum. Interestingly, KS-2
and -3, which exhibited high levels of Bcl-2 immunoreactivity (.40%
of positive cells) displayed a high resistance to serum deprivation
Figure 3. Viability assays of KS cells, human dermal fibroblasts, and
dermal microvascular EC during serum deprivation, as determined by
trypan blue exclusion test. After serum deprivation, cultures were harvested
at designated days as indicated on the x axis, and cells suspended in phosphate-
buffered saline were mixed with trypan blue and incubated for 3 min. Direct
counting of cells excluding and taking up the dye was performed with a
hemocytometer. The percentage of viable cells after total serum withdrawal is
shown here for KS cells (j), dermal fibroblasts (—), EC (d), and EC incubated
with the conditioned media from KS-3 cells (m). Error bars: SEM (n 5 3).
Table I. Comparative levels of Bcl-2 expression in KS cells in
respect to their resistance to serum deprivation
Bcl-2 % of viable cells after 15 d of
immunoreactivitya serum deprivationb
KS-1 (AIDS-related) 1 65 6 8
KS-2 (AIDS-related) 11 82 6 10
KS-3 (AIDS-related) 11 78 6 10
KS-4 (iatrogenic KS) 11 76 6 9
KS-5 (sporadic KS) 11 76 6 8
aBcl-2 imunoreactivity: 1, ,35% of positive cells; 11, .35% of positive cells.
bMean 6 SEM (n 5 3).
(Table I). No significant difference could be observed between AIDS
and non-AIDS KS cells.
Conditioned media from KS cells do not induce Bcl-2 expression
on EC and fail to promote their survival in serum-free
conditions As previous studies have shown that KS cells have
features of activated EC (Fiorelli et al, 1995), we next investigated the
effect of conditioned media from KS cells on EC. The proliferation
of EC treated with culture medium plus conditioned media from KS
cells (1:2) was greater than the one of EC treated with culture medium
alone (12% 6 2 vs 8 6 2% positive cells after a 2 h pulse of
Bromodeoxyuridine) (mean of triplicates; p , 0.05 by one-tailed
Student t test). This is in agreement with previous studies showing
that KS cell supernatants support endothelial cell growth (Ensoli et al,
1989; Albini et al, 1992). No Bcl-2 induction could still be detected
in EC treated with conditioned media from KS cells. Analogously, no
Bcl-2 induction could be observed in dermal fibroblasts.
Because cytokines and growth factors play an important role in KS
and because some growth factors have been found to promote the
survival and proliferation of EC (Kondo et al, 1994), we considered
the possibility that the supernatant from KS cell cultures might protect
EC from cell death. KS cells supernatants still had no effect on the
survival of EC cultures (Fig 4). Analogously, conditioned media from
KS cells did not promote the cell survival of fibroblasts.
DISCUSSION
Using an immunohistochemical approach, we have shown that KS-
derived cells overexpress Bcl-2, a protooncogene known to antagonize
apoptosis. This high level of Bcl-2 was in contrast with low expression
of Bax, which may be considered as the counterpart of Bcl-2, promoting
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Figure 4. Conditioned media from KS cells fails to prevent the cell
death induced by serum deprivation. Phase contrast microscopy of EC
after 28 h of culture in serum-free conditioned media from KS cells. A
substantial proportion of EC has produced blebs and has detached from the
plate. Scale bar: 200 µm.
apoptosis. Two previous studies have shown an in vivo overexpression
of Bcl-2 in KS spindle-shaped cells (Bohan Morris et al, 1996; Dada
et al, 1996). Another study found that KS spindle cells in vivo and
in vitro essentially expressed Bcl-xl with little or no Bcl-2 (Foreman
et al, 1996). The expression of Bcl-2 was confirmed here by a western
blot analysis.
Interestingly, we have found high levels of Bcl-2 in AIDS-related
KS-derived cells as well as in cells derived from iatrogenic and sporadic
KS. These findings suggest that Bcl-2 upregulation may be important
in the pathogenesis of KS and are in line with the view that the
different epidemiologic forms of KS represent a uniform disease
spectrum with common pathogenic denominators.
Although the origin of the KS tumor cells remains unclear, it is
commonly believed that they derive from EC. This is based on a
variety of data including expression of similar surface antigens as well
as phenotypic conversion of normal endothelial cells into spindle-
shaped KS-like cells when grown in KS media (Rutgers et al, 1986;
Fiorelli et al, 1995). In this respect, we tested the effect of supernatant
from KS cells on EC; however, we detected no effect of cell-free
products secreted by KS cells on either the expression of Bcl-2 by EC
or their survival in serum deprivation conditions. This suggests that
the overexpression of Bcl-2 in KS-derived cells is mediated by a
mechanism that is not cytokine induced.
Our findings suggest that the spindle cells derived from KS lesions
have a survival advantage and may adequately represent the tumor cells
of KS. Supporting this view, we found that KS-derived cells were
more resistant than EC or fibroblasts to cell death mediated by serum
deprivation. Although the constitutive expression of Bcl-2 has been
proposed to be involved in cell protection from apoptosis mediated
by growth factor deprivation (Garland and Halestrap, 1997), the
mechanism of this resistance remains unclear. Future functional experi-
ments, such as microinjection of anti-sense cDNA could probably
give more information regarding the relationship between the high
expression of bcl-2 and the resistant nature of KS cells to death. One
possible mechanism, which is consistent with the long doubling time
of KS cells reported here and in other studies (Benelli et al, 1994), is
the prolongation of the G1 phase of the cell cycle, with subsequent
facilitation of a prolonged metabolically dormant state from which cells
recover with high efficiency (Borner, 1996).
The pathogenic mechanisms leading to Bcl-2 overexpression are
not fully understood. Previous studies have found Bcl-2 upregulation
and consequent blocking of apoptosis by viral gene products. For
example, Epstein–Barr virus may induce direct activation of Bcl-2 in
infected B cell lines (Finke et al, 1992) and herpes simplex virus-2 may
act cooperatively with IFN-γ in the induction of Bcl-2 and the
associated survival of infected neurons (Geiger et al, 1995). Whether a
similar mechanism is operative in KS is conjectural. Recently, a new
herpesvirus, designated HHV-8, has been detected in all forms of KS;
however, its pathogenic role remains to be determined. Interestingly,
Cheng et al (1997) found that HHV-8 encodes a Bcl-2 homolog that
inhibits apoptosis but neither homodimerizes nor heterodimerizes with
other Bcl-2 family members. It seems very unlikely that this homolog
could react with the antibody we used because we and others did not
maintain HHV-8 in KS cell cultures (Lebbe´ et al, 1995; Simonart et al,
1996). Whether HHV-8 plays a role in the expression of bcl-2 in
cultured KS cells is conjectural. If this is so, the absence of HHV-8
DNA sequences in KS-derived cells may suggest a ‘‘hit and run’’
mechanism.
In conclusion, we have found consistent, strong immunoexpression
of Bcl-2 in cells derived from cutaneous KS lesions, irrespective
of epidemiologic subtype. The consequences of upregulated Bcl-2
expression in KS cells may be a prolonged spindle cell viability that,
when coupled with cytokine- or viral-induced cellular proliferation,
likely contributes to the pathogenesis and progression of KS.
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